AI assistant
BridgeBio Pharma, Inc. — Director's Dealing 2025
Nov 19, 2025
30604_dirs_2025-11-19_2664f85d-d736-4b0d-aafb-93f08fd82b8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BridgeBio Pharma, Inc. (BBIO)
CIK: 0001743881
Period of Report: 2025-11-17
Reporting Person: Lo Andrew (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-17 | Common Stock | S | 36801 | $66.6263 | Disposed | 17887 | Direct |
| 2025-11-17 | Common Stock | S | 3798 | $67.056 | Disposed | 14089 | Direct |
| 2025-11-18 | Common Stock | S | 24007 | $65.2315 | Disposed | 81576 | Indirect |
| 2025-11-18 | Common Stock | S | 30993 | $66.049 | Disposed | 50583 | Indirect |
Footnotes
F1: Represents the weighted average sale price of the shares sold from $65.975 to $66.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2: Represents the weighted average sale price of the shares sold from $66.975 to $67.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3: Represents the weighted average sale price of the shares sold from $64.58 to $65.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4: Represents the weighted average sale price of the shares sold from $65.58 to $66.52 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.